financetom
Business
financetom
/
Business
/
Microsoft develops AI model for videogames
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microsoft develops AI model for videogames
Feb 19, 2025 8:25 AM

(Reuters) - Microsoft ( MSFT ) has developed an artificial intelligence model of a videogame which can help generate visuals and actions, the company announced on Wednesday.

The model, called Muse, was made in collaboration with Ninja Theory, a developer under Xbox Game Studios - Microsoft's ( MSFT ) gaming division.

The push towards AI comes as videogame development costs continue to rise. Spending on new games has also been weak as consumers stick to proven titles due to economic uncertainty.

"We are already using Muse to develop a real-time playable AI model trained on other first-party games, and we see potential for this work to one day benefit both players and game creators," said Fatima Kardar, corporate vice president for gaming AI.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vanda Pharmaceuticals Shares Rise; Cycle Pharmaceuticals' Buyout Offer Rejected Again
Vanda Pharmaceuticals Shares Rise; Cycle Pharmaceuticals' Buyout Offer Rejected Again
Oct 17, 2024
11:55 AM EDT, 10/14/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) shares rose 11% in recent Monday trading after the company rejected a second unsolicited buyout proposal from Cycle Pharmaceuticals for $8 a share. The offer, received on Sept. 23, is economically identical to the previously evaluated and rejected indication of interest, and is another opportunistic attempt to purchase...
Vanda Pharmaceuticals rejects Cycle Pharma's second takeover offer
Vanda Pharmaceuticals rejects Cycle Pharma's second takeover offer
Oct 17, 2024
Oct 14 (Reuters) - Vanda Pharmaceuticals ( VNDA ) on Monday rejected UK-based Cycle Pharmaceuticals' second takeover proposal, which values the drugmaker at $8 per share despite a drop in Vanda's stock following the FDA's rejection of its stomach condition drug. The terms of Cycle Pharma's proposal are economically identical to the previously evaluated and rejected offer, Vanda said in...
IBM's Constant Currency Revenue Likely to Grow in Q3, UBS Says
IBM's Constant Currency Revenue Likely to Grow in Q3, UBS Says
Oct 17, 2024
12:01 PM EDT, 10/14/2024 (MT Newswires) -- International Business Machines ( IBM ) Q3 constant currency revenue is likely to grow about 3%, a slight decrease from Q2, UBS Securities said in a note to clients on Monday. UBS analysis indicates that the company's Q3 reported revenue will align with or slightly exceed its estimate of $14.9 billion, compared with...
Vanda Pharmaceuticals rejects Cycle Pharma's second takeover offer
Vanda Pharmaceuticals rejects Cycle Pharma's second takeover offer
Oct 17, 2024
(Reuters) -Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals' second takeover proposal, which values the drugmaker at $8 per share despite a drop in Vanda's stock following the FDA's rejection of its stomach condition drug. The terms of Cycle Pharma's proposal are economically identical to the previously evaluated and rejected offer, Vanda said in a statement. WHY IT'S IMPORTANT Cycle...
Copyright 2023-2026 - www.financetom.com All Rights Reserved